A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors

• Yuting Yao ,

  Contributed equally to this work with: Yuting Yao, Li Wang

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Li Wang ,

  Contributed equally to this work with: Yuting Yao, Li Wang

  Affiliation Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• He Zhang,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California, United States of America

  ⨯
• Haibo Wang,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Xiaoping Zhao,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Yidan Zhang,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Leilei Zhang,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Xianqun Fan,

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Guanxiang Qian ,

  * E-mail: jifan@stanford.edu (J-FH); geshengfang@sjtu.edu.cn (SG); geshengfang@sjtu.edu.cn (SG); qiangx@shsmu.edu.cn (JH)

  ¶These authors also contributed equally to this work.

  Affiliation Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯
• Ji-Fan Hu ,

  * E-mail: jifan@stanford.edu (J-FH); geshengfang@sjtu.edu.cn (SG); geshengfang@sjtu.edu.cn (SG); qiangx@shsmu.edu.cn (JH)

  ¶These authors also contributed equally to this work.

  Affiliation VA Palo Alto Health Care System, Stanford University Medical School, Palo Alto, California, United States of America

  ⨯
• Shengfang Ge

  * E-mail: jifan@stanford.edu (J-FH); geshengfang@sjtu.edu.cn (SG); geshengfang@sjtu.edu.cn (SG); qiangx@shsmu.edu.cn (JH)

  ¶These authors also contributed equally to this work.

  Affiliations Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China, Department of Biochemistry and Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

  ⨯